NON CONTROLLING INTEREST (Details) - USD ($)	12 Months Ended
NON CONTROLLING INTEREST (Details) - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Net loss attributable to the non-controlling interest	$ (105,978)	$ (3,577)
Joseph DeSanto MD [Member]
Net loss	$ (1,731)	$ (5,113)
Average Non-controlling interest percentage of profit/losses	35.00%	35.00%
Net loss attributable to the non-controlling interest	$ (606)	$ (1,790)
BioCorRx Pharmaceuticals, Inc [Member]
Net loss	$ (435,421)	$ (7,384)
Average Non-controlling interest percentage of profit/losses	24.20%	24.20%
Net loss attributable to the non-controlling interest	$ (105,372)	$ (1,787)